CLPT
ClearPoint Neuro Inc

2,955
Loading...
Loading...
News
all
press releases
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -3.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates
RxSight (RXST) delivered earnings and revenue surprises of +20.00% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Zacks·4mo ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade
Zacks·4mo ago
News Placeholder
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons
Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons Parkinson's Disease Clinical Trial Uses Intraoperative MRI...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation...
PR Newswire·1y ago
News Placeholder
ClearPoint Neuro (CLPT, $6.73) Stochastic Oscillator left the oversold zone on April 01, 2024
This is a signal that CLPT's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Tickeron - Stocks·1y ago
News Placeholder
ClearPoint Neuro (CLPT, $6.81) Stochastic Oscillator left the oversold zone on March 28, 2024
This is a signal that CLPT's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Tickeron - Stocks·1y ago

Latest CLPT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.